Why the UK?

The UK Life Sciences sector is vibrant and growing.

A global life sciences hub

• The UK is home to more than 6,500 life sciences companies employing over 280,000 people

• Cambridge and Oxford are respectively ranked 1st and 5th globally as clusters for science and technology intensity

• More than 50% of sector employment is located outside of London and the South East

Lowest Corporation Tax rate in the G7, and attractive reliefs for R&D and capital allowances

A top destination for life sciences VC

• 4th largest cluster in the world for life sciences VC in 2022 after China, Massachusetts and San Francisco

• In 2022, the UK attracted more than a third of total VC raised by European companies and over half of the total deals in the sector

• UK biotech saw record breaking leaps in finance between 2012 and 2021, growing more than ten-fold

• All Top 25 global companies operate in the UK, and newer entrants too

A long-term Life Sciences developed with the of a strong partnership

High impact education

• Home to 4 of the universities for life

• Highest government research in Europe

• 13.4% of graduates education graduating sciences, mathematics programmes in amongst comparator

A global innovation

• Ranked 4th globally Global Innovation

• Home to 1 in 3 of ups founded in

• The largest biomedical across all stages

Home to the world’s cell and gene therapy

Why the UK?

Sciences Vision the sector, illustrative partnership working approach education and research the Top 10 global life sciences and medicine government spending on health Europe and 3rd globally graduates from tertiary graduating from natural mathematics and statistics 2019, 2nd globally comparator countries

World first research endeavours at scale: Having established the UK Biobank, 100,000 Genomes Project, and Our Future Health. Ambitious diverse genome and newborn sequencing efforts are now underway, and Our Future Health will recruit up to 5 million people to develop better ways to prevent, detect, and treat diseases.

The NHS is globally unique

• The NHS acts as an innovation partner to industry

• Longitudinal data resources from a diverse population of more than 65 million

• 1.6 million patient interactions every 24 hours

• First national health system in the world to introduce whole genome sequencing into routine care innovation hot spot globally in the 2022 Innovation Rankings of the life sciences startEurope in the last decade biomedical pipeline in Europe stages of development Booming exports and inward investment world’s 3rd largest therapy cluster

• Exported £24.2 billion worth of life sciences goods around the world in 2021

• Ranked 3rd in the world for number of inward investment projects in 2021

• All Top 25 global companies operate in the UK, and newer entrants too